Adicet Bio Inc (NASDAQ: ACET) on Tuesday, plunged -1.79% from the previous trading day, before settling in for the closing price of $1.12. Within the past 52 weeks, ACET’s price has moved between $0.89 and $3.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 342.10% over the last five years. The company achieved an average annual earnings per share of 53.78%. With a float of $66.22 million, this company’s outstanding shares have now reached $82.40 million.
The firm has a total of 143 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.67%, operating margin of -996.11%, and the pretax margin is -914.25%.
Adicet Bio Inc (ACET) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adicet Bio Inc is 19.64%, while institutional ownership is 51.43%. The most recent insider transaction that took place on Jun 05 ’24, was worth 8,437. In this transaction Director of this company sold 5,900 shares at a rate of $1.43, taking the stock ownership to the 5,900 shares. Before that another transaction happened on Jan 25 ’24, when Company’s Director bought 3,125,000 for $2.40, making the entire transaction worth $7,500,000. This insider now owns 7,526,359 shares in total.
Adicet Bio Inc (ACET) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.69 earnings per share (EPS) for the period topping the consensus outlook (set at -0.7) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.78% per share during the next fiscal year.
Adicet Bio Inc (NASDAQ: ACET) Trading Performance Indicators
Adicet Bio Inc (ACET) is currently performing well based on its current performance indicators. A quick ratio of 10.64 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.54 in one year’s time.
Technical Analysis of Adicet Bio Inc (ACET)
Analysing the last 5-days average volume posted by the [Adicet Bio Inc, ACET], we can find that recorded value of 0.99 million was lower than the volume posted last year of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 78.81%. Additionally, its Average True Range was 0.09.
During the past 100 days, Adicet Bio Inc’s (ACET) raw stochastic average was set at 26.29%, which indicates a significant decrease from 66.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.91% in the past 14 days, which was higher than the 66.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2842, while its 200-day Moving Average is $1.5855. Now, the first resistance to watch is $1.1367. This is followed by the second major resistance level at $1.1733. The third major resistance level sits at $1.2167. If the price goes on to break the first support level at $1.0567, it is likely to go to the next support level at $1.0133. Now, if the price goes above the second support level, the third support stands at $0.9767.
Adicet Bio Inc (NASDAQ: ACET) Key Stats
Market capitalization of the company is 90.64 million based on 82,401K outstanding shares. Right now, sales total 0 K and income totals -142,660 K. The company made 0 K in profit during its latest quarter, and -30,480 K in sales during its previous quarter.
